Maravai (MRVI) files Form 144 to sell 25,000 Class A shares
Maravai LifeSciences (MRVI) filed a Form 144 reporting an intent to sell 25,000 shares of Class A common stock through Fidelity Brokerage Services LLC on NASDAQ.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Maravai LifeSciences (MRVI) filed a Form 144 reporting an intent to sell 25,000 shares of Class A common stock through Fidelity Brokerage Services LLC on NASDAQ. The filing lists prior acquisitions of Class A shares by vesting and ESPP purchases on 03/15/2024, 04/30/2024, 10/31/2024, and 01/15/2025 totaling the disclosed prior receipts.
Insights
Form 144 flags a planned sale of 25,000 Class A shares via a broker.
The filing names Fidelity Brokerage Services LLC as the broker and lists 25,000 Class A shares with a transaction date reference of 06/09/2026. This is a routine notice required for certain restricted or control securities disposed of in reliance on Rule 144.
Future filings will confirm actual sale execution and proceeds; cash‑flow treatment is not stated in the provided excerpt.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Vesting financial
ESPP Purchase financial
Brokerage transaction market
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does MRVI's Form 144 report?
Who is the broker named in the MRVI Form 144?
Does the Form 144 show proceeds or completed sales for MRVI?
AI-generated analysis. How Rhea-AI works. Not financial advice.